Serum concentrations of erlotinib at a dose of 25 mg daily

由 Costa, D.B., Kobayashi, S., Yeo, W.-L., Hamada, A.
出版 2014

SILVER - POLY(3-HIDROXY-BUTYRATE) [AG-PHB] NANOCOMPOSITE: A PREPARATIVE EVALUATION

由 , S. Y. Yeo, W. L. Tan, M. Abu Bakar and J.Ismail
出版 2007

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

由 Chuah, B.Y.S., Yeo, W.-L., Guo, J.Y., Lim, S.-G., Yap, H.-L., Goh, B.-C., Lee, S.-C.
出版 2014

Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: Results of a meta-analysis of randomized controlled trials

由 Soo, R.A., Loh, M., Mok, T.S., Ou, S.-H.I., Cho, B.-C., Yeo, W.-L., Tenen, D.G., Soong, R.
出版 2014

Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes

由 Chan, D., Yeo, W.-L., Tiemsim Cordero, M., Wong, C.-I., Chuah, B., Soo, R., Tan, S.-H., Lim, S.-E., Goh, B.-C., Lee, S.-C.
出版 2014

Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients

由 Wong, A.L.-A., Yap, H.-L., Yeo, W.-L., Soong, R., Ng, S.-S., Wang, L.-Z., Cordero, M.T., Yong, W.-P., Goh, B.-C., Lee, S.-C.
出版 2014

Chemotherapy-induced tumor gene expression changes in human breast cancers

由 Lee, S.-C., Xu, X., Lim, Y.-W., Lau, P., Sukri, N., Lim, S.-E., Yap, H.L., Yeo, W.-L., Tan, P., Tan, S.-H., McLeod, H., Goh, B.-C.
出版 2014

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

由 Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
出版 2011

Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer

由 Wong, N.-S., Seah, E.Z.H., Wang, L.-Z., Yeo, W.-L., Yap, H.-L., Chuah, B., Lim, Y.-W., Ang, P.C.S., Tai, B.-C., Lim, R., Goh, B.-C., Lee, S.-C.
出版 2014

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies

由 Yong, W.P., Goh, B.C., Soo, R.A., Toh, H.C., Ethirajulu, K., Wood, J., Novotny-Diermayr, V., Lee, S.C., Yeo, W.L., Chan, D., Lim, D., Seah, E., Lim, R., Zhu, J.
出版 2014

Identification and engineering of 32 membered antifungal macrolactone notonesomycins

由 Goh, F., Zhang, M.M., Lim, T.R., Low, K.N., Nge, C.E., Heng, E., Yeo, W.L., Sirota, F.L., Crasta, S., Tan, Z., Ng, V., Leong, C.Y., Zhang, H., Lezhava, A., Chen, S.L., Hoon, S.S., Eisenhaber, F., Eisenhaber, B., Kanagasundaram, Y., Wong, F.T., Ng, S.B.
出版 2021

Cost of Medical Care of Patients with Advanced Serious Illness in Singapore (COMPASS): Prospective cohort study protocol

由 Teo, I, Singh, R, Malhotra, C, Ozdemir, S, Dent, R.A, Kumarakulasinghe, N.B, Yeo, W.L, Cheung, Y.B, Malhotra, R, Kanesvaran, R, Yee, A.C.P, Chan, N, Wu, H.Y, Chin, S.M, Allyn, H.Y.M, Yang, G.M, Neo, P.S.H, Nadkarni, N.V, Harding, R, Finkelstein, E.A
出版 2020

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

由 Yasuda, H., Park, E., Yun, C.-H., Sng, N.J., Lucena-Araujo, A.R., Yeo, W.-L., Huberman, M.S., Cohen, D.W., Nakayama, S., Ishioka, K., Yamaguchi, N., Hanna, M., Oxnard, G.R., Lathan, C.S., Moran, T., Sequist, L.V., Chaft, J.E., Riely, G.J., Arcila, M.E., Soo, R.A., Meyerson, M., Eck, M.J., Kobayashi, S.S., Costa, D.B.
出版 2014